STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)							1 Months Ended	3 Months Ended
	Mar. 16, 2022	Feb. 28, 2022	Mar. 30, 2021	Jan. 22, 2021	Jan. 14, 2021	Dec. 23, 2020	Mar. 31, 2022	Mar. 31, 2022	Mar. 31, 2021	Mar. 29, 2022	Mar. 17, 2022	Dec. 31, 2021	Jan. 31, 2021	Jan. 25, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Class of warrant right exercise price	$ 0.35				$ 1.20									$ 0.35
Issuance of common stock, net of issuance costs, shares	16,393,445
Proceeds from warrants exercised									$ 6,671,000
Residual value of warrants and stock offering						$ 2,500,000
Reclassification as a reduction in additional paid-in capital						300,000
Warrant liability, issuance costs						500,000
Common stock, par value							$ 0.001	$ 0.001				$ 0.001
Fair Value Adjustment of Warrants									6,200,000
Proceeds from Issuance of Warrants									$ 1,000,000.0
Preferred Stock, Shares Issued							0	0				0
Preferred stock per share							$ 1,000	$ 1,000
Conversion price							$ 0.305	$ 0.305
Deferred offering costs							$ 104,000	$ 104,000				$ 694,000
Cantor Fitzerald and Co [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from Issuance of Common Stock			$ 50,000,000.0
Deferred offering costs		$ 700,000
Series A Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred Stock, Shares Issued	3,000.000435
Series B Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred Stock, Shares Issued	2,000.00029
Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Converted share											6,557,378
Series A Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Converted share										9,836,067
Series A and Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Class of warrant right exercise price							$ 0.381	$ 0.381
Warrants issued							819,672	819,672
Sale of stock, price per share							$ 125	$ 125
Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Class of warrant right exercise price				$ 0.624
Sales Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Payments to Acquire Investments		$ 400,000
Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net of issuance costs, shares				10,688,043
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Estimated fair value, liability						5,200,000
Exisitng Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from warrants exercised					$ 9,200,000	$ 7,200,000
Noninterest Expense Offering Cost					$ 800,000
Exisitng Warrant [Member] | Monte Carlo Simulation Model [Member]
Subsidiary, Sale of Stock [Line Items]
Noninterest Expense Offering Cost				$ 100,000
Pre-funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Class of warrant right exercise price					$ 1.375
Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants					$ 8,100,000
Common Stock Warrants [Member] | Monte Carlo Simulation Model [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants				5,800,000
Placement Agent Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants					500,000
Placement Agent Common Stock Warrants [Member] | Monte Carlo Simulation Model [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants				$ 400,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net of issuance costs, shares	16,393,445
Fair Value Adjustment of Warrants					1,400,000
Warrants issued													2,420,910		5,238,043
Common Stock [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net of issuance costs, shares														8,016,033
Common stock, par value				$ 0.001
Sale of stock, price per share				$ 0.125
Common Stock [Member] | Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued, shares				8,016,033
Additional Paid-in Capital [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants					100,000
Classified Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants					$ 700,000
Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from warrants exercised	$ 5.0			$ 6,700,000
Warrants issued				480,962
Warrant or right, reason for issuance, description								The holder of the March 2022 Warrants may not exercise any portion of such warrants to the extent that the holder would own more than 4.99% of the outstanding common stock immediately after exercise, which percentage may be changed at the holder’s election to a lower percentage at any time or to a higher percentage not to exceed 9.99% upon 61 days’ notice to the Company
Proceeds from Issuance of Warrants				$ 1,000,000.0
Warrants [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercisable description				Each January 25 Warrant is exercisable for one share of Common Stock at an exercise price of $1.20 per share. The January 25 Warrants are immediately exercisable and will expire five years from the date of issuance
Warrant or right, reason for issuance, description				A holder may not exercise any portion of the January 25 Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock immediately after exercise, which percentage may be changed at the holder’s election to a lower percentage at any time or to a higher percentage not to exceed 9.99% upon 61 days’ notice to the Company. The Company also issued to designees of the placement agent, warrants to purchase 6.0% of the aggregate number of common stock shares and pre-funded warrants sold in the offering
Warrants [Member] | Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued				10,688,043
Warrant One [Member]
Subsidiary, Sale of Stock [Line Items]
Remeasurement loss				$ 3,600,000
Warrant One [Member] | Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued						10,688,043
Warrants exercised				10,688,043
Series A and Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from warrants exercised							$ 4,500,000
Residual value of warrants and stock offering							1,900,000	$ 1,900,000
Noninterest Expense Offering Cost							0.2
Fair Value Adjustment of Warrants							300,000
Series A and Series B Preferred Stock [Member] | Monte Carlo Simulation Model [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants							3,000,000.0
Series A and Series B Preferred Stock [Member] | Placement Agent Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants							$ 100,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued, shares					6,670,000	5,450,000
Class of warrant right exercise price						$ 0.001
Issuance of common stock, net of issuance costs, shares					9,090,910
Warramt term					5 years	5 years
Common stock, par value					$ 0.001
IPO [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net of issuance costs, shares					9,090,910	10,688,043
IPO [Member] | Pre-Funded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Class of warrant right exercise price					$ 0.001	$ 0.001
Issuance of common stock, net of issuance costs, shares					2,420,910	5,238,043
Offering price per share					$ 1.099	$ 0.7475
IPO [Member] | Common Stock and Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Offering price per share						0.7485
IPO [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Class of warrant right exercise price					1.20	0.624
Offering price per share					$ 1.10
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant, Exercise Price, Increase						$ 0.9356
Estimated fair value, liability						$ 300,000
Private Placement [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net of issuance costs, shares					545,455	641,283
Percentage of exercise of warrants						125.00%
Percentage of warrant exercise price					125.00%